Botox Best For People With Most Severe, Frequent Headaches; Significantly Reduces Number of Attacks, Study Shows
PHILADELPHIA, June 23 -- The more frequent and severe the migraine attacks, the better anti-wrinkle drug Botox seems to work to prevent the headaches, suggests a study being presented at the 47th Annual Scientific Meeting of the American Headache Society (AHS). More than four million American migraine sufferers experience the headaches more than 15 days a month. People with near-daily migraines suffered from half as many days of headaches after being treated with Botox injections. Botox also has fewer side effects than other medications used for migraine prevention.
NASAL SPRAY PROVIDES MIGRAINE PAIN RELIEF TO ADOLESCENTS AND TEENS, STUDY SAYS
Kids get migraines, too, and nasal spray can provide relief. Currently there are no FDA-approved drugs available to treat migraines in young people but, according to a new study being presented at the 47th Annual Scientific Meeting of the American Headache Society, teens and adolescents got relief from migraine pain by using zolmitriptan nasal spray. More than half of kids in the study were pain-free within two hours of using zolmitriptan nasal spray. More than one in 10 adolescents and teens suffer from debilitating headaches, missing school and social activities as a result.
MORE THAN 11 MILLION WITH MIGRAINE HEADACHES COULD BENEFIT FROM PREVENTIVE MEDICINE
Findings from American Migraine Prevalence and Prevention Study:
One of the best ways to prevent a migraine is to stop it before it starts, but only one in 10 migraine sufferers takes medication to prevent the attacks, according to a national survey. Eight times that many people, more than 11 million, could benefit from preventive medications, according to findings of a study being presented at the 47th Annual Scientific Meeting of the American Headache Society.
IV MEDICATION CAN RELIEVE ENTRENCHED MIGRAINE, SHOULD BE PRESCRIBED IN THE ER BEFORE NARCOTICS, RESEARCH SUGGESTS
More than 800,000 people end up in the emergency room every year seeking relief for migraine pain, and half of them are prescribed narcotics. New research being presented at the 47th Annual Scientific Meeting of the American Headache Society shows intravenous delivery of a nonsteroidal anti-inflammatory (NSAID) drug is more effective than narcotics, and has fewer potential problems.
For full news releases, please visit http://www.headachemeeting.org.
- Contact Information
- Annie Henry
- Media Contact
- American Headache Society
- Contact via E-mail
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.